Carlos Risco

Madrid, MD 28015, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis.

Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis.

Journal: Antibiotics (Basel, Switzerland)

Published: September 11, 2024

Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis.

Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis.

Journal: Viruses

Published: September 28, 2023

Response from the authors to the letter commenting the article "Trends in COVID-19-related in-hospital mortality in women and men".

Response from the authors to the letter commenting the article "Trends in COVID-19-related in-hospital mortality in women and men".

Journal: Gaceta medica de Mexico

Published: September 12, 2023

Trends in COVID-19-related in-hospital mortality in women and men.

Trends in COVID-19-related in-hospital mortality in women and men.

Journal: Gaceta medica de Mexico

Published: March 17, 2023

Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain.

Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 23, 2023

Azithromycin in patients with COVID-19: a systematic review and meta-analysis.

Azithromycin in patients with COVID-19: a systematic review and meta-analysis.

Journal: The Journal of antimicrobial chemotherapy

Published: August 05, 2021

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?

Journal: The Lancet. Rheumatology

Published: March 03, 2021

Cross-sectional evaluation of the interaction between activity relative-time expenditure and comorbidity concerning physical quality of life.

Cross-sectional evaluation of the interaction between activity relative-time expenditure and comorbidity concerning physical quality of life.

Journal: Medicine

Published: November 25, 2020

The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.

The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.

Journal: Internal and emergency medicine

Published: July 08, 2020

Early Combination of Tocilizumab and Corticosteroids: An Upgrade in Anti-inflammatory Therapy for Severe Coronavirus Disease (COVID).

Early Combination of Tocilizumab and Corticosteroids: An Upgrade in Anti-inflammatory Therapy for Severe Coronavirus Disease (COVID).

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 05, 2020

The association between treatment with heparin and survival in patients with Covid-19.

The association between treatment with heparin and survival in patients with Covid-19.

Journal: Journal of thrombosis and thrombolysis

Published: June 02, 2020

Epidemiology of measles in vaccinated people, Spain 2003-2014.

Epidemiology of measles in vaccinated people, Spain 2003-2014.

Journal: Enfermedades infecciosas y microbiologia clinica

Published: February 05, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026